$57.46
-4.19-6.8%
Last update: Nov 5, 6:37 PM
Arrowhead Pharmaceuticals Inc
ARWRNASDAQ
The average analyst price target for Arrowhead Pharma is $89.28, 56.6% above the current price. Of 15 analysts, 12 rate it Buy and 3 Hold. Targets range from $17 to $126. The latest change came on Oct 15, 2026, when UBS assumed coverage of Arrowhead Pharma with a Buy rating and a $109 price target.
Price Target Range — 13 Quarters
Analyst Consensus — 15 Analysts
Rating Trend — Last 9 Months
